DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Griffith DE, Eagle G, Thomson R. et al; CONVERT Study Group.
Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT): a prospective, open-label, randomized study.
Am J Respir Crit Care Med 2018;
198 (12) 1559-1569
We do not assume any responsibility for the contents of the web pages of other providers.